K

Kearney

Global management consulting on strategy, transformation

Healthcare & Life Sciences Practice Principal - Pharma R&D Strategy

Full-Time
$245k - $270k+ Discretionary performance bonus + Equity-based awards + 401(k) match + Profit sharing + Home office stipend
Expert
MBA
Boston, MA, USA+6 moreMore locations: Washington, DC, USA | San Francisco, CA, USA | Dallas, TX, USA | Chicago, IL, USA | New York, NY, USA | Atlanta, GA, USA
Remote
ConsultingStrategy & Management Consulting

About the job

Requirements
  • At least 10 years of professional experience.
  • Significant management consulting experience at the Principal level or equivalent.
  • A strong traditional consulting background with experience leading strategy engagements within pharmaceutical research and development and clinical development.
  • Experience advising pharmaceutical and biopharma clients in one or more of the following areas: clinical development, drug development, clinical operations, regulatory affairs, pharmacovigilance or drug safety, clinical trial feasibility, clinical development program strategy, research and development operating models, or digital strategy and transformation within research and development organizations.
  • Deep pharmaceutical industry expertise; candidates focused primarily on medtech or consumer health are less aligned for this role.
  • Demonstrated ability to lead strategic advisory engagements rather than operational execution-focused delivery work.
  • Strong executive presence and ability to influence senior stakeholders.
  • Experience managing proposal development, client pitches, and business development efforts.
  • Proven ability to independently lead multiple complex workstreams and client relationships.
  • Exceptional communication, analytical, and leadership skills.
  • Willingness to travel as required.
Responsibilities
  • Lead large, complex strategy engagements for pharmaceutical and biopharma clients across research and development and clinical development functions.
  • Advise senior executives on clinical development strategy, drug development strategy, clinical trial strategy and operating models, clinical operations transformation, regulatory affairs strategy, pharmacovigilance and drug safety strategy, clinical trial feasibility and development planning, and digital strategy and transformation across research and development organizations.
  • Support clients in designing and optimizing research and development operating models and organizational effectiveness.
  • Drive strategic problem solving from issue identification through analysis, synthesis, and executive recommendation development.
  • Translate complex analyses into clear, actionable insights for C-suite stakeholders.
  • Lead cross-functional teams and independently manage high-impact engagement workstreams.
  • Serve as a trusted advisor to senior client leadership across pharmaceutical and biopharma organizations.
  • Provide thought leadership on evolving trends across pharmaceutical research and development, clinical development, and digital transformation.
  • Originate and expand client relationships across Pharma and Life Sciences accounts.
  • Support growth of Kearney’s Pharma R&D Strategy capabilities within the practice.
  • Lead proposal development and contribute to senior-level client pitches.
  • Identify opportunities to expand strategic advisory relationships within existing and new clients.
  • Contribute to the development of intellectual capital and differentiated market offerings across Pharma R&D and clinical development.
  • Mentor and develop junior consultants and engagement teams.
  • Foster a collaborative, high-performing team environment.
  • Provide coaching and oversight across multiple engagements to ensure quality and impact.
  • Help build and strengthen Kearney’s Pharma R&D Strategy presence within Life Sciences.
Desired Qualifications
  • An MBA is preferred.

About the company

Kearney provides management consulting services to corporations, governments, and nonprofit organisations. It helps clients with strategy, operations, procurement, mergers and acquisitions, organisational transformation, sustainability, and digital analytics. By analyzing data and applying methods like AI and machine learning, Kearney supports data-driven decision-making and develops digital operating models. The firm assists with supply chain optimisation, cost reduction, growth strategies, and large-scale transformation programmes across industries such as consumer, retail, energy, healthcare, financial services, industrials, technology, media, and transportation, as well as the public sector. In sustainability and ESG work, Kearney helps organisations adapt to regulations and pursue sustainable practices. Since its founding in Chicago in 1926 as part of McKinsey’s early history, it evolved from A.T. Kearney to Kearney in 2020 through a management-led evolution.

Company Size

5,001-10,000

Company Stage

Acquired

Total Funding

$569M

Headquarters

Chicago, Illinois

Founded

1926

Get referred to Kearney

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Beroe MAX launched June 3, 2026, targeting tariffs, risk, ESG, and margins.
  • Kearney's January 2025 Project Partners and February 2025 IMTEK acquisitions expand delivery depth.
  • The 2026 ServiceNow partnership won a 30% cost-reduction case study, supporting sales.

What critics are saying

  • Consultor reported nearly half of Paris partners left in 15 months, through March 2026.
  • MAX and ServiceNow intensify competition against Accenture, Deloitte, and Oliver Wyman.
  • A shrinking partnership and CFO transition after Laurent Guerard's death signal leadership instability.

What makes Kearney unique

  • Kearney pairs strategy consulting with procurement execution through Beroe MAX and Kinaxis integrations.
  • Its ServiceNow alliance sells agentic AI process redesign, not narrow workflow automation.
  • IMTEK and Project Partners deepen supply chain and SAP transformation delivery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Unlimited Paid Time Off

Hybrid Work Options

Home Office Stipend

Gym Membership

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
PR Newswire
Jun 3rd, 2026
Beroe and Kearney launch MAX, AI decision engine connecting procurement data to execution

Beroe and Kearney have launched MAX, an AI-native decision engine for procurement, at DPW NYC. The platform connects intelligence and execution systems, continuously surfacing margin opportunities whilst optimising risk and ESG compliance. MAX addresses procurement's expanding mandate by providing real-time recommendations when market conditions shift, such as tariff changes or commodity price spikes. Built on a neurosymbolic framework, it combines Beroe's 30 million live market signals with Kearney's proprietary methodology and applies them against a company's own spend data. The product was developed with a Strategic Advisory Council of 13 global procurement organisations. It enables category managers to monitor every supplier and category continuously, rather than focusing selectively on the top 20% of spend. MAX will be available to select customers over the coming months.

Umbrex
Apr 29th, 2026
Profile of Kearney

Access a detailed profile of Kearney consulting firm: history, key figures, innovations, global presence, financials, and peer comparison.

PR Newswire
Feb 11th, 2026
Kearney partners with ServiceNow to deploy agentic AI for enterprise transformation

Kearney, a global management consulting firm, has partnered with ServiceNow to help organisations implement agentic AI at enterprise scale. The collaboration combines Kearney's strategic consulting expertise with ServiceNow's AI Platform to accelerate digital transformation and operational efficiency. The partnership focuses on three areas: operational excellence through faster exception handling, workflow optimisation with improved process velocity, and end-to-end impact via AI-enabled process orchestration. Kearney's approach, called BPR.ai, reimagines entire business processes rather than simply automating individual tasks. In a recent client engagement, the methodology helped transform an IT organisation into an AI-first operations model, achieving over 30% annual cost reduction whilst accelerating deployment of agentic AI across IT services. The offering targets sales, operations and service functions across organisations.

PR Newswire
Feb 27th, 2025
Kearney Acquires IMTEK for Supply Chain Boost

Kearney has acquired IMTEK Inc., a consulting and systems integration firm specializing in supply chain planning and execution. This acquisition enhances Kearney's capabilities in supply chain transformations by leveraging IMTEK's expertise with platforms like Kinaxis. The move aligns with Kearney's strategy to use inorganic growth to better serve clients, offering comprehensive planning solutions from strategy development to technology implementation.

PR Newswire
Jan 14th, 2025
Kearney Acquires Project Partners for SAP Transformation

Kearney has acquired Project Partners Management GmbH to enhance its SAP transformation capabilities, particularly in SAP S4/HANA. This acquisition strengthens Kearney's ability to support clients throughout their SAP transformation journeys. The move aligns with Kearney's strategy of using acquisitions to boost growth and service offerings. Project Partners will complement Kearney's expertise, enabling comprehensive support for clients leveraging SAP and AI.